+34 976 503 597
+34 976 503 597

Test for the differential detection of Bordetella pertussis, Bordetella parapertussis y Bordetella homesii

The Real Respiratory Bacterial Panel 2 kit, based on the real-time PCR technique, allows the qualitative detection of Bordetella pertussis (BP), Bordetella parapertussis (BPP) and Bordetella holmesii (BH) in samples from the respiratory tract (nasopharyngeal swabs, nasopharyngeal washings, nasopharyngeal aspirates, etc.).

The Bordetella genus is formed of 8 species, of which only the following are human pathogens: B. pertussis, B. parapertussis and B. holmesii. The disease caused by B. pertussis and B. parapertussis is known as whooping cough. It is a major risk today, with 50 million cases per year and 300,000 deaths (mostly among infants and neonates). Therefore, a reliable diagnosis is required to initiate appropriate treatment and contact prophylaxis.

Diagnosis of Bordetellae based on culture or serological techniques has special requirements, is sometimes very time-consuming or does not provide good sensitivity data. For this reason, molecular techniques based on the detection of insertion sequences (IS) can be an interesting alternative to increase the sensitivity in the detection of these pathogens.

The Real Respiratory Bacterial Panel 2 test provides a simple, inexpensive and reliable way to detect all infections caused by bordetellas B. pertussis, B. parapertussis and B. holmesii.

search 1

Detection and differentiation of 3 species

variedad tipos muestra validados

Several samples validated

secuencias insercion mayor sensibilidad

Insertion sequences for greater sensitivity

control endogeno interno

Internal endogenous control

menos de 30 minutos

Results in 30 minutes

Our products for the differential detection of Bordetella pertussis, Bordetella parapertussis y Bordetella homesii

Promotional Sheet
CE Decl.
Reference No.
Real Respiratory Bacterial Panel 2
PCR real time
DNA extracted from respiratory tract samples (nasopharyngeal swab/washes/aspirates, exudates)

Several samples validated. The test has been designed and validated for use with DNA obtained from respiratory samples of different nature, which allows the professional to take the sample from one area or another to ensure the capture of as much of the pathogen as possible. Specifically, the kit has been validated with DNA extracted from nasopharyngeal aspirate/wash, nasopharyngeal swab and exudates.

The insertion sequences used for diagnosis are repeated throughout the genome of the bacterium, which allows for more sensitive detection.

The use of internal endogenous controls ensures that the extraction, amplification and subsequent detection are correct.

The kit can be transported refrigerated, thus avoiding the use of dry ice, which makes the process cheaper and easier.

Contact us for more

    Frequently Asked Questions

    No, the test is qualitative. It gives a Ct value, so there is a possibility to compare the values obtained for each sample. Theoretically, the higher the Ct value, the lower the amount of initial DNA, but no numerical correlation can be established.

    No. The kit can be transported under refrigerated conditions (2-8°C), maintaining its specifications.

    The PCR process is completed within 30 minutes.

    The CFX96 Real-time PCR detection system (BioRad), QuantStudio 5 Real-time PCR system (Applied Biosystems), Gentier 96 Real-time PCR (Tianlong) and Gentier 48 E Real-Time PCR (Tianlong) have been validated for use. The use of other systems must be validated by the user.